Pandemic Did Not Slow Center of Breakthrough Medicines in King of Prussia’s Discovery Labs
Despite the pandemic, development of the Center for Breakthrough Medicines in King of Prussia’s Discovery Labs innovation hub is still on track to be finalized and occupied by the end of next year, writes Queen Muse for the Philadelphia Magazine.
Developer Brian O’Neill and biotech executive Audrey Greenberg have joined forces with health-care investment firm Deerfield Management from New York City to develop the 630,000-square-foot cell and gene therapy manufacturing facility.
The site broke ground in December 2019. When it is completed, the property will offer contract development and manufacturing organization space and research and development labs, as well as administrative offices and dining, daycare, and fitness amenities…